On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                A Estratégia Conjunta Continental Africana para a COVID-19 é sustentada pela necessidade de limitar a transmissão, prevenir mortes e reduzir os danos associados. A participação das nações africanas em ensaios clínicos é um passo essencial para garantir que sejam gerados dados suficientes so...bre a segurança e eficácia dos candidatos a vacinas mais promissores entre as populações da região.
Embora a actual actividade de ensaios clínicos COVID-19 no continente seja limitada, a África tem uma experiência e capacidades substanciais para conduzir ensaios clínicos de vacinas preventivas numa série de doenças, e muitas organizações no continente estão a trabalhar incansavelmente para ajudar a preparar ensaios adicionais sobre potenciais vacinas COVID-19.
Disponível em inglês, francês e português
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                COVID Reference 23 May 2021
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This website has been created to provide accurate and up-to-date information about Sputnik V.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Issue Brief no.8. January 18,2021
Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies,... implementation of the vaccination, ethical considerations, as well as educational materials in English and other languages.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Issue Brief no. 16. 20 Sept 2021.
Many studies have shown the effectiveness of vaccination against COVID-19 and that it protects against severe
illness. A high vaccination rate is needed to combat the pandemic worldwide. Due to misinformation and myths,
there is still a great hesitancy to vaccina...te . With this Issue Brief, we would like to present various myths and provide
you with educational materials on the respective topics for communication in the MEDBOX
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Revised working paper following AVAREF meeting February 2019.
 WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This is an updated introductory two-page document that defines AIDS vaccines and reviews key developments in the field.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                6 June 2022
 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...is document has been updated: Version 6 June 2022.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This document provides answers to FAQs healthcare providers and staff may have about COVID-19 vaccines
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                14 July 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
COVID-19 vaccines have proven to be safe, ...effective and life-saving. Like all vaccines, they do not fully protect everyone who is vaccinated, and  we do not yet know how well they can prevent people from transmitting the virus to others. So as well as getting vaccinated, we must also continue with other measures to fight the pandemic. 
Available in English, French, Spanish, Arabic, Chinese and Russian
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV. 
This document is also available in Arabic and Portuguese.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Policy
25 February 2015 Vol 7 Issue 276 276fs8
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio...n appeared.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Available in English, French, Portuguese and Arabic
Successful  immunization  of  a  critical  mass  of  the  African  population  with one or several safe and efficacious COVID-19 vaccines.Key objectives1.  Accelerate  African  involvement  in  the  clinical  development  of  a  vaccine. 2.  Ensur...e  African  countries  can  access  a  sufficient  share  of  the  global vaccine supply.3.  Remove  barriers  to  widespread  delivery  and  uptake  of  effective  vaccines across Africa.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                 The  Committee  examined   the   clinical   development   of   Ebola   virus  vaccines  and  conducted  an  inventory  of  available  data  on  their  safety.  It  also  reviewed  3  generic  issues:  updating  a  global  strategy  on  vaccine  safety,  use  of  a    network  of  distributed  data ... to  monitor  the  safety  of  vaccines  and  case  studies  of  communication about the safety of human papillomavirus  (HPV)  vaccines.
Weekly epidemiological record/Relevé épidémiologique hebdomadaire 12 JULY 2019, 94th YEAR / 12 JUILLET 2019, 94e ANNÉENo  28,  2019,  94, 309–316
                                                                    more